Based on the mutational profile of The Cancer Genome Atlas (TCGA) derived from the cBioPortal, the alteration rate of PTPRT was 29.9% in melanoma and >10% in patients with lung adenocarcinoma, stomach, colorectal, uterine, and esophageal cancers.13 This evidence concerns the gene PTPRT and esophageal cancer.